Sanofi unit bid: Private group lifts offer, pledging to save French jobs
The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the maker of France's best-selling drug.
The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the maker of France's best-selling drug.
What's Your Reaction?
